Nataliіa Yaroslavivna Muzyka
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Nataliіa Yaroslavivna Muzyka has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Iryna Bilyk
Ivano-Frankivsk National Medical University of the Ministry of Health of Ukraine , Ukraine
2 shared publications - Liliia Budniak
I. Horbachevsky Ternopil National Medical University
2 shared publications Kateryna Sadohurska
Higher State Educational Establishment of Ukraine „Bukovinian State Medical University“, Ukraine
1 shared publicationRayisa Kosuba
Higher State Educational Establishment of Ukraine „Bukovinian State Medical University“, Ukraine
1 shared publicationRoksolana Basaraba Basaraba
Higher State Educational Establishment of Ukraine „Bukovinian State Medical University“, Ukraine
1 shared publication- Svitlana Mykhailivna Marchyshyn
I. Horbachevsky Ternopil National Medical University
1 shared publication
Latest Publications
- Open Access
- 31 December 2025
- Published by Publishing House Helvetica (Publications) in Health & Education
- No. 4,p. 83-88
COMMODITY ANALYSIS OF MEDICAL DEVICES FOR BLOOD PRESSURE MEASUREMENT
Medical devices for blood pressure measurement are an essential component of the pharmacy assortment and are widely used for screening, diagnosis, and monitoring of cardiovascular diseases. A rational analysis of their assortment is necessary to ensure availability, functional adequacy, and safe use, as well as to optimize the selection of blood pressure monitors according to the needs of different consumer groups. The aim of the study was to conduct a commodity analysis of the assortment of medical devices for blood pressure measurement available in the pharmacy segment of the pharmaceutical market of Ukraine. The study was based on data from the Compendium online reference source and the information platform Tabletki.ua. Logical, system-analytical, comparative, statistical, and graphical research methods were applied. As of November 2025, the pharmacy assortment of blood pressure monitors comprised 272 items. Automatic devices dominated the market, accounting for 75.4% of the assortment, while manual and semi-automatic models were represented to a much lesser extent. Upper-arm blood pressure monitors predominated (239 items), reflecting their higher accuracy and broader applicability. The range of cuff sizes extended from 7 to 46 cm, with a clear predominance of cuffs intended for adult users. Manufacturers increasingly equip devices with additional functions, such as measurement memory, arrhythmia detection, result averaging, and smart features, which enhance measurement accuracy and user convenience. The analysis revealed a concentration of the assortment among several leading international brands, while Ukrainian manufacturers accounted for 9.2%. The Ukrainian pharmaceutical market of blood pressure monitors is characterized by a diverse and functionally rich assortment, the dominance of automatic devices, and the leading role of international manufacturers alongside a noticeable segment of domestic products. The results may be used to optimize the assortment policy of pharmacy institutions and improve pharmaceutical provision for the population.
- 31 December 2025
- Published by Publishing House Helvetica (Publications) in Health & Education
- No. 4,p. 83-88
Open AccessCOMMODITY ANALYSIS OF MEDICAL DEVICES FOR BLOOD PRESSURE MEASUREMENT
Medical devices for blood pressure measurement are an essential component of the pharmacy assortment and are widely used for screening, diagnosis, and monitoring of cardiovascular diseases. A rational analysis of their assortment is necessary to ensure availability, functional adequacy, and safe use, as well as to optimize the selection of blood pressure monitors according to the needs of different consumer groups. The aim of the study was to conduct a commodity analysis of the assortment of medical devices for blood pressure measurement available in the pharmacy segment of the pharmaceutical market of Ukraine. The study was based on data from the Compendium online reference source and the information platform Tabletki.ua. Logical, system-analytical, comparative, statistical, and graphical research methods were applied. As of November 2025, the pharmacy assortment of blood pressure monitors comprised 272 items. Automatic devices dominated the market, accounting for 75.4% of the assortment, while manual and semi-automatic models were represented to a much lesser extent. Upper-arm blood pressure monitors predominated (239 items), reflecting their higher accuracy and broader applicability. The range of cuff sizes extended from 7 to 46 cm, with a clear predominance of cuffs intended for adult users. Manufacturers increasingly equip devices with additional functions, such as measurement memory, arrhythmia detection, result averaging, and smart features, which enhance measurement accuracy and user convenience. The analysis revealed a concentration of the assortment among several leading international brands, while Ukrainian manufacturers accounted for 9.2%. The Ukrainian pharmaceutical market of blood pressure monitors is characterized by a diverse and functionally rich assortment, the dominance of automatic devices, and the leading role of international manufacturers alongside a noticeable segment of domestic products. The results may be used to optimize the assortment policy of pharmacy institutions and improve pharmaceutical provision for the population.
- Open Access
- 22 September 2025
- Published by Ternopil State Medical University in Здобутки клінічної і експериментальної медицини
- No. 3,p. 72-76
ANALYSIS OF THE ASSORTMENT OF DIETARY SUPPLEMENTS FOR THE NORMALIZATION OF VISUAL FUNCTION
SUMMARY. Vision is essential for human activity, yet over 2.2 billion people worldwide face visual impairments, many of which are preventable. Digital screen exposure further exacerbates eye health issues. While treatment options exist, their cost makes prevention increasingly relevant. The use of plant-based dietary supplements offers a viable preventive strategy. Analyzing their assortment, composition, and dosage forms is key to improving quality control and guiding the development of effective products for visual function support. The aim – to investigate the pharmaceutical assortment of dietary supplements for the normalization of visual function. Material and Methods. The objects of the study were the directory of Compendium online and online resources such as Tabletki.ua and Apteki.ua. The study employed marketing analysis, graphical representation, logical generalization, and mathematical-statistical methods. Results. As of April 2025, the pharmaceutical assortment comprised 104 dietary supplements for the normalization of visual function. The analysis of the assortment revealed a predominance of domestically produced dietary supplements, accounting for 55.77 %. The leaders among them were Beauty and Health, LLC (10.34 %) and Elit-Pharm, LLC (8.61 %). Imported dietary supplements originated from 16 countries, with the highest shares coming from Germany and the United States (19.57 % each). The majority of dietary supplements had a multi-component composition (86.54 %). The most common dosage forms were capsules and tablets. Conclusions. The domestic pharmaceutical market of dietary supplements for the normalization of visual function has been analyzed. The results indicate a predominance of domestically produced products, a multi-component structure of the assortment, and a variety of dosage forms, highlighting the high potential for further research and development based on plant-derived raw materials.
- 22 September 2025
- Published by Ternopil State Medical University in Здобутки клінічної і експериментальної медицини
- No. 3,p. 72-76
Open AccessANALYSIS OF THE ASSORTMENT OF DIETARY SUPPLEMENTS FOR THE NORMALIZATION OF VISUAL FUNCTION
SUMMARY. Vision is essential for human activity, yet over 2.2 billion people worldwide face visual impairments, many of which are preventable. Digital screen exposure further exacerbates eye health issues. While treatment options exist, their cost makes prevention increasingly relevant. The use of plant-based dietary supplements offers a viable preventive strategy. Analyzing their assortment, composition, and dosage forms is key to improving quality control and guiding the development of effective products for visual function support. The aim – to investigate the pharmaceutical assortment of dietary supplements for the normalization of visual function. Material and Methods. The objects of the study were the directory of Compendium online and online resources such as Tabletki.ua and Apteki.ua. The study employed marketing analysis, graphical representation, logical generalization, and mathematical-statistical methods. Results. As of April 2025, the pharmaceutical assortment comprised 104 dietary supplements for the normalization of visual function. The analysis of the assortment revealed a predominance of domestically produced dietary supplements, accounting for 55.77 %. The leaders among them were Beauty and Health, LLC (10.34 %) and Elit-Pharm, LLC (8.61 %). Imported dietary supplements originated from 16 countries, with the highest shares coming from Germany and the United States (19.57 % each). The majority of dietary supplements had a multi-component composition (86.54 %). The most common dosage forms were capsules and tablets. Conclusions. The domestic pharmaceutical market of dietary supplements for the normalization of visual function has been analyzed. The results indicate a predominance of domestically produced products, a multi-component structure of the assortment, and a variety of dosage forms, highlighting the high potential for further research and development based on plant-derived raw materials.
- Open Access
- 16 November 2020
- Published by CBU Research Institute in Proceedings of CBU in Medicine and Pharmacy
- Vol. 1, 77-81
NANOCHROMIUM CITRATE: ANTIHYPERGLYCEMIC AND PANCREATOPROTECTIVE ACTION AGAINST UNDERLYING DEXAMETHASONE-INDUCED DIABETES MELLITUS
INTRODUCTION: The Ukrainian State Scientific-Research Institute of Nanobiotechnology and Resources Saving has received nanochromium citrate (NCC), a new chrome compound, by means of the electric pulse aquananotechnology method. OBJECTIVES: to determine nanochromium citrate efficacy with experimental dexamethasone-induced diabetes through the results of antihyperglycemic activity and its effect on the pancreatic histological structure. METHODS: diabetes mellitus was simulated by dexamethasone administration on 18-month male rats. The morphological structure of the pancreas was examined in comparison with metformin. Examination of the pancreas morphological structure considered the amount, distribution and size of the pancreatic islets and their cellular shape. RESULTS: on the 14th day of simulated diabetes mellitus the preventitive -therapeutic indication of nanochromium citrate promoted a decrease of glycemia level twice. The administration of nanochromium citrate with underlying diabetes mellitus is not inferior to metformin and its protective effect on the pancreas morphological structure exceeds the effect of metformin. CONCLUSION: nanochromium citrate of experimental dexamethasone-induced diabetes mellitus in rats decreases the glycemia level twice which does not differ reliably from the effect of metformin antihyperglycemic. The cytoprotective effect of nanochromium citrate produced on the histological structure of the pancreas is found to exceed metformin action.
- 16 November 2020
- Published by CBU Research Institute in Proceedings of CBU in Medicine and Pharmacy
- Vol. 1, 77-81
Open AccessNANOCHROMIUM CITRATE: ANTIHYPERGLYCEMIC AND PANCREATOPROTECTIVE ACTION AGAINST UNDERLYING DEXAMETHASONE-INDUCED DIABETES MELLITUS
INTRODUCTION: The Ukrainian State Scientific-Research Institute of Nanobiotechnology and Resources Saving has received nanochromium citrate (NCC), a new chrome compound, by means of the electric pulse aquananotechnology method. OBJECTIVES: to determine nanochromium citrate efficacy with experimental dexamethasone-induced diabetes through the results of antihyperglycemic activity and its effect on the pancreatic histological structure. METHODS: diabetes mellitus was simulated by dexamethasone administration on 18-month male rats. The morphological structure of the pancreas was examined in comparison with metformin. Examination of the pancreas morphological structure considered the amount, distribution and size of the pancreatic islets and their cellular shape. RESULTS: on the 14th day of simulated diabetes mellitus the preventitive -therapeutic indication of nanochromium citrate promoted a decrease of glycemia level twice. The administration of nanochromium citrate with underlying diabetes mellitus is not inferior to metformin and its protective effect on the pancreas morphological structure exceeds the effect of metformin. CONCLUSION: nanochromium citrate of experimental dexamethasone-induced diabetes mellitus in rats decreases the glycemia level twice which does not differ reliably from the effect of metformin antihyperglycemic. The cytoprotective effect of nanochromium citrate produced on the histological structure of the pancreas is found to exceed metformin action.